Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11138
Title: Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
Austin Authors: Wei, Joe;Waithman, Jason;Lata, Roleen;Mifsud, Nicole A;Cebon, Jonathan S ;Kay, Thomas;Smyth, Mark J;Sadler, Anthony J;Chen, Weisan
Affiliation: Ludwig Institute for Cancer Research, Austin Health, Heidelberg, Melbourne, Victoria, Australia
Issue Date: 18-Oct-2010
Publication information: Journal of Immunology (baltimore, Md. : 1950) 2010; 185(10): 6013-22
Abstract: The initiation of antitumor immunity relies on dendritic cells (DCs) to cross-present cell-associated tumor Ag to CD8(+) T cells (T(CD8+)) due to a lack of costimulatory molecules on tumor cells. Innate danger signals have been demonstrated to enhance cross-priming of T(CD8+) to soluble as well as virally encoded Ags; however, their effect on enhancing T(CD8+) cross-priming to cell genome-encoded Ags remains unknown. Furthermore, influenza A virus (IAV) has not been shown to enhance antitumor immunity. Using influenza-infected allogeneic cell lines, we show in this study that T(CD8+) responses to cell-associated Ags can be dramatically enhanced due to enhanced T(CD8+) expansion. This enhanced cross-priming in part involves TLR7- but not TLR3-mediated sensing of IAV and is entirely dependent on MyD88 and IFN signaling pathways. We also showed that the inflammasome-induced IL-1 and IFN-γ did not play a role in enhancing cross-priming in our system. We further demonstrated in our ex vivo system that CD8(+) DCs are the only APCs able to prime TCR-transgenic T(CD8+). Importantly, plasmacytoid DCs and CD8(-) DCs were both able to enhance such priming when provided in coculture. These observations suggest that IAV infection of tumor cells may facilitate improved cross-presentation of tumor Ags and may be used to augment clinical vaccine efficacy.
Gov't Doc #: 20956347
URI: https://ahro.austin.org.au/austinjspui/handle/1/11138
DOI: 10.4049/jimmunol.1002129
Journal: Journal of Immunology (Baltimore, Md. : 1950)
URL: https://pubmed.ncbi.nlm.nih.gov/20956347
Type: Journal Article
Subjects: Animals
Antigen Presentation.immunology
Antigens, Neoplasm.immunology
CD8-Positive T-Lymphocytes.immunology
Cancer Vaccines.immunology
Cross-Priming.immunology
Cytokines.biosynthesis.immunology
Dendritic Cells.immunology
Enzyme-Linked Immunosorbent Assay
Influenza A virus.immunology
Interferon Type I.immunology
Lymphocyte Activation.immunology
Membrane Glycoproteins.immunology
Mice
Mice, Inbred C57BL
Mice, Knockout
Neoplasms.immunology
Orthomyxoviridae Infections.immunology
Polymerase Chain Reaction
Signal Transduction.immunology
Toll-Like Receptor 7.immunology
Appears in Collections:Journal articles

Show full item record

Page view(s)

24
checked on Dec 2, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.